"Designing Growth Strategies is in our DNA"
Region : Global | Published Date: Upcoming | Report ID: FBI100672| Status : Upcoming
Stents are small wire mesh tubes which are used in the treatment of narrowed arteries in the body. Stents are used in opening the narrow arteries that get blocked due to fat deposition during coronary heart disease. This further helps in the reduction of symptoms associated with angina (chest pain) and helps to reduce the chances of a heart attack. The stents are made up of different materials such as metals, polymers, and plastics.
The stents are inserted inside the clogged artery and then the balloon is inflated which locks the stents in an artery as the stents get expanded. This opens the artery and helps the blood to flow more easily. Patients who undergo angioplasty using stents recovers at a faster rate than patients who undergo coronary artery bypass surgery. Growing prevalence of cardiovascular disease globally and high adoption of stents in treating coronary heart disease are likely to boost the stents market during the forecast period.
To get information on various segments, share your queries with us
Increasing prevalence of coronary heart disease and growing awareness about the new stent implants used for the treatment for various cardiac abnormalities are the major factors likely to drive the global stents market during the projected period. In addition, growing demand for minimally invasive, effective technology, and high adoption of medical implants in treating heart diseases are anticipated to enhance the market of stents device during the forecast period.
However, due to the high cost associated with heart surgeries is likely to hamper the growth in global stents market during the forecast period.
Some of the major companies that are present in stents market are BIOTRONIK, Medtronic, BD, Boston Scientific Corporation, Abbott., Cardinal Health, Elixir Medical Corporation, Terumo Corporation, Biosensors International Group, Ltd. Meril Life Sciences Pvt. Ltd., among others.
· Coronary Stent
· Vascular Stents
· Ureteral Stent
· Esophageal Stent
· Biliary Stents
· Dual Therapy Stents (DTS)
· Bioresorbable Vascular Scaffolds (BVS)
· Bio-engineered Stents
· Drug-Eluting Stents (DES)
· Bare Metal Stents (BMS)
- Stainless Steels
- Poly-l-lactide acid (PLLA)
- Polycaprolactone (PCL)
· Helical spiral
· Individual rings
· Sequential rings
By End User
· Specialty Clinics
· Ambulatory Surgery Centers
· North America (U.S. and Canada)
· Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico, and Rest of Latin America)
· Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)
Among end users, hospitals are anticipated to hold the largest market share owing to the emergency visits and need for immediate heart surgeries of patients with coronary heart diseases. Coronary stents are likely to boost the growth in stents markets owing to the growing need of coronary stents in treating various cardiovascular disease. For instance, according to the recent data published by Centers for Disease Control and Prevention (CDC), it is estimated that 735,000 American populations are diagnosed with heart disease and 370,000 people die due to coronary heart disease annually and this growing prevalence of heart disease is likely to boost the stents market during the forecast period.
Geographically, the global stents market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold a major portion in the global stents market during the forecast period due to the growing incidence of cardiovascular diseases and increase in the launch of effective stents devices through the acquisitions among many players. In addition, increasing expenditure in the research and development activities by leading players are likely to boost the stents device market during the forecast period. For instance, American Heart Association funds research activity related to cardiovascular disease and stroke when compared to any other organization. Stent market in the Asia Pacific is anticipated to expand the stents market at a significant rate during the analysis period owing to the increase in the patient population and growing investments in providing better healthcare infrastructure by government funded organization